| Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020 E Alm, EK Broberg, T Connor, EB Hodcroft, AB Komissarov, ... Eurosurveillance 25 (32), 2001410, 2020 | 256 | 2020 |
| Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2 A Popa, JW Genger, MD Nicholson, T Penz, D Schmid, SW Aberle, ... Science translational medicine 12 (573), eabe2555, 2020 | 227 | 2020 |
| SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8+ T cell responses B Agerer, M Koblischke, V Gudipati, LF Montaño-Gutierrez, M Smyth, ... Science immunology 6 (57), eabg6461, 2021 | 161 | 2021 |
| Viral variant-resolved wastewater surveillance of SARS-CoV-2 at national scale F Amman, R Markt, L Endler, S Hupfauf, B Agerer, A Schedl, L Richter, ... Nature biotechnology 40 (12), 1814-1822, 2022 | 102 | 2022 |
| Epistasis-driven identification of SLC25A51 as a regulator of human mitochondrial NAD import E Girardi, G Agrimi, U Goldmann, G Fiume, S Lindinger, V Sedlyarov, ... Nature communications 11 (1), 6145, 2020 | 93 | 2020 |
| Selective Mediator dependence of cell-type-specifying transcription MG Jaeger, B Schwalb, SD Mackowiak, T Velychko, A Hanzl, H Imrichova, ... Nature genetics 52 (7), 719-727, 2020 | 87 | 2020 |
| Type I interferon signaling disrupts the hepatic urea cycle and alters systemic metabolism to suppress T cell function A Lercher, A Bhattacharya, AM Popa, M Caldera, MF Schlapansky, ... Immunity 51 (6), 1074-1087. e9, 2019 | 74 | 2019 |
| ACE2 is the critical in vivo receptor for SARS-CoV-2 in a novel COVID-19 mouse model with TNF-and IFNγ-driven immunopathology R Gawish, P Starkl, L Pimenov, A Hladik, K Lakovits, F Oberndorfer, ... Elife 11, e74623, 2022 | 46 | 2022 |
| The ERBB-STAT3 axis drives Tasmanian devil facial tumor disease L Kosack, B Wingelhofer, A Popa, A Orlova, B Agerer, B Vilagos, P Majek, ... Cancer Cell 35 (1), 125-139. e9, 2019 | 45 | 2019 |
| Repression of the B cell identity factor Pax5 is not required for plasma cell development GJ Liu, M Jaritz, M Wöhner, B Agerer, A Bergthaler, SG Malin, ... Journal of Experimental Medicine 217 (11), e20200147, 2020 | 21 | 2020 |
| Emergence of SARS-CoV-2 Alpha lineage and its correlation with quantitative wastewater-based epidemiology data E Radu, A Masseron, F Amman, A Schedl, B Agerer, L Endler, T Penz, ... Water research 215, 118257, 2022 | 16 | 2022 |
| Human tripartite motif protein 52 is required for cell context-dependent proliferation S Benke, B Agerer, L Haas, M Stöger, A Lercher, L Gabler, I Kiss, ... Oncotarget 9 (17), 13565, 2018 | 16 | 2018 |
| Hepatocyte-intrinsic type I interferon signaling reprograms metabolism and reveals a novel compensatory mechanism of the tryptophan-kynurenine pathway in viral hepatitis A Lercher, AM Popa, C Viczenczova, L Kosack, K Klavins, B Agerer, ... PLoS Pathogens 16 (10), e1008973, 2020 | 11 | 2020 |
| T Cell-Intrinsic CDK6 Is Dispensable for Anti-Viral and Anti-Tumor Responses In Vivo K Klein, A Witalisz-Siepracka, D Gotthardt, B Agerer, F Locker, ... Frontiers in Immunology 12, 650977, 2021 | 6 | 2021 |
| Rapid, early and accurate SARS-CoV-2 detection using RT-qPCR in primary care: a prospective cohort study (REAP-1) W Leber, O Lammel, M Redlberger-Fritz, ME Mustafa-Korninger, ... BMJ open 11 (8), e045225, 2021 | 4 | 2021 |
| A repetitive acidic region contributes to the extremely rapid degradation of the cell-context essential protein TRIM52 K Hacker, S Benke, B Agerer, S Scinicariello, V Budroni, GA Versteeg Scientific Reports 9 (1), 7901, 2019 | 3 | 2019 |
| The serine’s call: Suppressing interferon responses B Agerer, A Lercher, A Bergthaler Cell Metabolism 33 (5), 849-850, 2021 | 2 | 2021 |
| Nuclear receptor corepressor 1 controls regulatory T cell subset differentiation and effector function V Stolz, R Rica, C Zhu, T Preglej, P Hamminger, D Hainberger, ... bioRxiv, 2022.03. 24.485609, 2022 | 1 | 2022 |
| Characterization of CD8 T cell-mediated mutations in the immunodominant epitope GP33-41 of lymphocytic choriomeningitis virus M Smyth, K Khamina, A Popa, V Gudipati, B Agerer, A Lercher, L Kosack, ... Frontiers in Immunology 12, 638485, 2021 | 1 | 2021 |
| NCOR1 controls Treg subset differentiation and effector function V Stolz, R Rica, C Zhu, ESR Freitas, T Preglej, P Hamminger, ... EUROPEAN JOURNAL OF IMMUNOLOGY 53, 128-128, 2023 | | 2023 |
